| Naslov: | Patch testing with the European baseline series and 10 added allergens : single centre study of 748 patients |
|---|
| Avtorji: | ID Bizjak, Mojca (Korespondenčni avtor)
ID Adamič, Katja (Avtor)
ID Bajrović, Nisera (Avtor)
ID Eržen, Renato (Avtor)
ID Jošt, Maja (Avtor)
ID Kopač, Peter (Avtor)
ID Košnik, Mitja (Avtor)
ID Lalek, Nika (Avtor)
ID Zidarn, Mihaela (Avtor)
ID Dinevski, Dejan (Avtor) |
|---|
| Datoteke: |  RAZ_Bizjak_Mojca_2022.pdf (1,26 MB)
MD5: 1F4F45BEA26B68B7F7F94B299890234C
 https://doi.org/10.1111/cod.14178
|
|---|
| Jezik: | Angleški jezik |
|---|
| Vrsta gradiva: | Znanstveno delo |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: | MF - Medicinska fakulteta
|
|---|
| Opis: | Background: The European baseline series (EBS) of contact allergens is subject to change. An allergen is considered for inclusion when routine patch testing of patients with suspected contact dermatitis results in ≥ 0.5% prevalence rate.
Objectives: We aimed to determine the frequency of sensitizations to 30 EBS allergens and 10 locally added allergens. Additionally, we assessed the strength and evolution of reactions to all tested allergens and co-reactivity of additional allergens.
Methods: Patch testing with our baseline series of 40 allergens was done in 748 consecutive adults. Tests were applied to the upper back and removed by patients after 48 hours. Readings were done on day 3 (D3) and D6 or D7 (D6/7). Positive reactions fulfilled the criteria of at least one plus (+) reaction. Retrospective analysis was done.
Results: Eight allergens not listed in the EBS had ≥ 0.5% prevalence rate (i.e., cocamidopropyl betaine, thiomersal, disperse blue mix 106/124, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea, propylene glycol, Compositae mix II, and dexamethasone-21-phosphate), and 16.6% of positive reactions would have been missed without D6/7 readings.
Conclusion: We propose further studies to evaluate whether cocamidopropyl betaine, disperse blue mix 106/124, 2-bromo-2-nitropropane-1,3-diol, diazolidinyl urea, and Compositae mix II need to be added to the EBS. |
|---|
| Ključne besede: | clinical epidemiology, baseline series, contact sensitization, patch tests, simultaneous reactivity |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Poslano v recenzijo: | 27.04.2022 |
|---|
| Datum sprejetja članka: | 21.06.2022 |
|---|
| Datum objave: | 23.06.2022 |
|---|
| Založnik: | Blackwell |
|---|
| Leto izida: | 2022 |
|---|
| Št. strani: | Str. 439-446 |
|---|
| Številčenje: | Letn. 87, Št. 5 |
|---|
| PID: | 20.500.12556/DKUM-81986  |
|---|
| UDK: | 616-097 |
|---|
| COBISS.SI-ID: | 112721411 |
|---|
| DOI: | 10.1111/cod.14178 |
|---|
| ISSN pri članku: | 1600-0536 |
|---|
| Datum objave v DKUM: | 13.07.2023 |
|---|
| Število ogledov: | 320 |
|---|
| Število prenosov: | 71 |
|---|
| Metapodatki: |    |
|---|
| Področja: | Ostalo
|
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Skupna ocena: | (0 glasov) |
|---|
| Vaša ocena: | Ocenjevanje je dovoljeno samo prijavljenim uporabnikom. |
|---|
| Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
